Viridian Therapeutics, Inc. VRDN Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Product | ||||||
| Collaboration | $135K+2.3% | $132K-78.0% | $600K+3,429% | $17K-83.0% | $100K+38.9% | |
| License | $6K— | —— | $70M— | —— | $0— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Viridian Therapeutics, Inc. break its business down?
- Viridian Therapeutics, Inc. (VRDN) reports total revenues by product across 2 parts — Collaboration and License. Each is extracted from the segment footnotes and tracked over time.
- Where does Viridian Therapeutics, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Viridian Therapeutics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.